

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein activation cascade (GO:0072376) | 8.91391488 |
| 2 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 8.29529243 |
| 3 | Fc-gamma receptor signaling pathway (GO:0038094) | 8.29529243 |
| 4 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 8.29529243 |
| 5 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 8.18695980 |
| 6 | positive regulation of respiratory burst (GO:0060267) | 7.57017470 |
| 7 | retina homeostasis (GO:0001895) | 7.24163780 |
| 8 | humoral immune response (GO:0006959) | 7.22734985 |
| 9 | positive regulation of B cell differentiation (GO:0045579) | 6.59378513 |
| 10 | negative regulation of B cell proliferation (GO:0030889) | 6.50480198 |
| 11 | B cell receptor signaling pathway (GO:0050853) | 6.49382608 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.38143129 |
| 13 | glomerular filtration (GO:0003094) | 6.23658630 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.75513504 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.75513504 |
| 16 | regulation of B cell differentiation (GO:0045577) | 5.59531380 |
| 17 | renal filtration (GO:0097205) | 5.57586682 |
| 18 | negative regulation of glucose import (GO:0046325) | 5.37336292 |
| 19 | myeloid dendritic cell differentiation (GO:0043011) | 5.33303654 |
| 20 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.25857257 |
| 21 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.15597528 |
| 22 | Golgi transport vesicle coating (GO:0048200) | 5.11744489 |
| 23 | COPI coating of Golgi vesicle (GO:0048205) | 5.11744489 |
| 24 | regulation of B cell proliferation (GO:0030888) | 5.09859716 |
| 25 | positive regulation of Rho protein signal transduction (GO:0035025) | 5.09055642 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.83280885 |
| 27 | regulation of respiratory burst (GO:0060263) | 4.82326784 |
| 28 | myeloid dendritic cell activation (GO:0001773) | 4.69538672 |
| 29 | cellular extravasation (GO:0045123) | 4.63797091 |
| 30 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.52104788 |
| 31 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.49790448 |
| 32 | negative regulation of glucose transport (GO:0010829) | 4.41590833 |
| 33 | negative regulation of bone resorption (GO:0045779) | 4.40772339 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.39320815 |
| 35 | response to protozoan (GO:0001562) | 4.25720761 |
| 36 | fucose catabolic process (GO:0019317) | 4.25406733 |
| 37 | L-fucose metabolic process (GO:0042354) | 4.25406733 |
| 38 | L-fucose catabolic process (GO:0042355) | 4.25406733 |
| 39 | positive regulation of Rap GTPase activity (GO:0032854) | 4.23602907 |
| 40 | cellular response to zinc ion (GO:0071294) | 4.21815461 |
| 41 | detection of bacterium (GO:0016045) | 4.16810346 |
| 42 | mature B cell differentiation (GO:0002335) | 4.13654076 |
| 43 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.05766612 |
| 44 | detection of other organism (GO:0098543) | 4.02062325 |
| 45 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.87010577 |
| 46 | positive thymic T cell selection (GO:0045059) | 3.81260302 |
| 47 | N-acetylneuraminate metabolic process (GO:0006054) | 3.75087232 |
| 48 | regulation of Rap GTPase activity (GO:0032317) | 3.71297810 |
| 49 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.70305228 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.67599605 |
| 51 | mannose metabolic process (GO:0006013) | 3.64843704 |
| 52 | signal peptide processing (GO:0006465) | 3.64786723 |
| 53 | positive regulation of immunoglobulin production (GO:0002639) | 3.61490650 |
| 54 | immune response-activating signal transduction (GO:0002757) | 3.59616743 |
| 55 | regulation of B cell activation (GO:0050864) | 3.57568116 |
| 56 | dendritic cell differentiation (GO:0097028) | 3.56454712 |
| 57 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.53239917 |
| 58 | B cell proliferation (GO:0042100) | 3.52822619 |
| 59 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.48420475 |
| 60 | antibacterial humoral response (GO:0019731) | 3.46221025 |
| 61 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.44571739 |
| 62 | Fc receptor signaling pathway (GO:0038093) | 3.44412912 |
| 63 | negative regulation of bone remodeling (GO:0046851) | 3.44209758 |
| 64 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.43911687 |
| 65 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.43583010 |
| 66 | negative regulation of B cell activation (GO:0050869) | 3.43076865 |
| 67 | antimicrobial humoral response (GO:0019730) | 3.40820505 |
| 68 | B cell homeostasis (GO:0001782) | 3.39180040 |
| 69 | maternal placenta development (GO:0001893) | 3.39081600 |
| 70 | cellular response to type I interferon (GO:0071357) | 3.38550841 |
| 71 | type I interferon signaling pathway (GO:0060337) | 3.38550841 |
| 72 | bone resorption (GO:0045453) | 3.38118766 |
| 73 | hepatocyte apoptotic process (GO:0097284) | 3.37673478 |
| 74 | positive regulation of nuclease activity (GO:0032075) | 3.37239421 |
| 75 | protein retention in ER lumen (GO:0006621) | 3.37009968 |
| 76 | Fc-epsilon receptor signaling pathway (GO:0038095) | 3.35790138 |
| 77 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.33981600 |
| 78 | regulation of gamma-delta T cell activation (GO:0046643) | 3.33022265 |
| 79 | peptidyl-asparagine modification (GO:0018196) | 3.30892327 |
| 80 | activation of immune response (GO:0002253) | 3.24018711 |
| 81 | negative regulation of osteoclast differentiation (GO:0045671) | 3.22514585 |
| 82 | dendritic cell chemotaxis (GO:0002407) | 3.20745625 |
| 83 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.20709059 |
| 84 | apoptotic cell clearance (GO:0043277) | 3.20642199 |
| 85 | regulation of nuclease activity (GO:0032069) | 3.20161560 |
| 86 | N-glycan processing (GO:0006491) | 3.19688955 |
| 87 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.19154043 |
| 88 | mature B cell differentiation involved in immune response (GO:0002313) | 3.18706663 |
| 89 | positive regulation of B cell activation (GO:0050871) | 3.13451827 |
| 90 | thymic T cell selection (GO:0045061) | 3.13366775 |
| 91 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.13321719 |
| 92 | intestinal epithelial cell development (GO:0060576) | 3.13157730 |
| 93 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12480043 |
| 94 | negative thymic T cell selection (GO:0045060) | 3.11785357 |
| 95 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.11616030 |
| 96 | protein N-linked glycosylation (GO:0006487) | 3.08069295 |
| 97 | response to hydroperoxide (GO:0033194) | 3.06881681 |
| 98 | tolerance induction (GO:0002507) | 3.06578972 |
| 99 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.06369323 |
| 100 | response to interferon-alpha (GO:0035455) | 3.02870141 |
| 101 | cellular response to unfolded protein (GO:0034620) | 3.02679697 |
| 102 | natural killer cell differentiation (GO:0001779) | 3.00463755 |
| 103 | respiratory burst (GO:0045730) | 3.00389819 |
| 104 | regulation of cellular extravasation (GO:0002691) | 2.99324007 |
| 105 | positive regulation of B cell proliferation (GO:0030890) | 2.98010421 |
| 106 | response to endoplasmic reticulum stress (GO:0034976) | 2.95836460 |
| 107 | lymphocyte chemotaxis (GO:0048247) | 2.94093893 |
| 108 | negative T cell selection (GO:0043383) | 2.92098306 |
| 109 | negative regulation of cell killing (GO:0031342) | 2.91941354 |
| 110 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.91941354 |
| 111 | T cell selection (GO:0045058) | 2.89499237 |
| 112 | negative regulation of tissue remodeling (GO:0034104) | 2.86928481 |
| 113 | regulation of water loss via skin (GO:0033561) | 2.86843186 |
| 114 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.85542991 |
| 115 | regulation of superoxide anion generation (GO:0032928) | 2.85155070 |
| 116 | lymphocyte homeostasis (GO:0002260) | 2.83312769 |
| 117 | surfactant homeostasis (GO:0043129) | 2.82276194 |
| 118 | chronic inflammatory response (GO:0002544) | 2.81400810 |
| 119 | ER-nucleus signaling pathway (GO:0006984) | 2.80678358 |
| 120 | positive regulation of histone deacetylation (GO:0031065) | 2.80539991 |
| 121 | germinal center formation (GO:0002467) | 2.80151303 |
| 122 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.80041365 |
| 123 | regulation of fibroblast apoptotic process (GO:2000269) | 2.79763271 |
| 124 | cellular response to topologically incorrect protein (GO:0035967) | 2.79597953 |
| 125 | detection of external biotic stimulus (GO:0098581) | 2.78812968 |
| 126 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78037481 |
| 127 | defense response to protozoan (GO:0042832) | 2.74815310 |
| 128 | establishment of skin barrier (GO:0061436) | 2.73834578 |
| 129 | B cell activation (GO:0042113) | 2.73813729 |
| 130 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.73586917 |
| 131 | regulation of interferon-alpha production (GO:0032647) | 2.70095958 |
| 132 | cellular response to antibiotic (GO:0071236) | 2.70090030 |
| 133 | regulation of immunoglobulin production (GO:0002637) | 2.68807197 |
| 134 | COPII vesicle coating (GO:0048208) | 2.68487380 |
| 135 | response to type I interferon (GO:0034340) | 2.68460404 |
| 136 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.67591638 |
| 137 | positive T cell selection (GO:0043368) | 2.67384801 |
| 138 | regulation of germinal center formation (GO:0002634) | 2.66453356 |
| 139 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.64909560 |
| 140 | dendritic cell migration (GO:0036336) | 2.64742483 |
| 141 | innate immune response in mucosa (GO:0002227) | 2.62063822 |
| 142 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.61437614 |
| 143 | regulation of antigen processing and presentation (GO:0002577) | 2.59732786 |
| 144 | immunoglobulin mediated immune response (GO:0016064) | 2.58975599 |
| 145 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.56499545 |
| 146 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.56337707 |
| 147 | keratinization (GO:0031424) | 2.53486611 |
| 148 | organ or tissue specific immune response (GO:0002251) | 2.51966626 |
| 149 | interferon-gamma secretion (GO:0072643) | 2.48321413 |
| 150 | T cell migration (GO:0072678) | 2.47752379 |
| 151 | defense response to Gram-negative bacterium (GO:0050829) | 2.47739816 |
| 152 | multicellular organismal water homeostasis (GO:0050891) | 2.45522640 |
| 153 | positive regulation of antigen processing and presentation (GO:0002579) | 2.45118935 |
| 154 | phospholipid translocation (GO:0045332) | 2.44743546 |
| 155 | lipid translocation (GO:0034204) | 2.44743546 |
| 156 | regulation of integrin activation (GO:0033623) | 2.44167322 |
| 157 | negative regulation of myotube differentiation (GO:0010832) | 2.43613598 |
| 158 | protein-chromophore linkage (GO:0018298) | 2.42545338 |
| 159 | complement activation, classical pathway (GO:0006958) | 18.0928467 |
| 160 | complement activation (GO:0006956) | 13.8541076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.04685793 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.76666941 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.61324248 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.61023498 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.05207351 |
| 6 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.86719815 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.73668708 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.62712509 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.51903343 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.48438500 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.35618985 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.27543475 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.11304120 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.10702026 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.05888889 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.96286034 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.81014395 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.75092989 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.74681776 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.64445451 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.60761396 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50412054 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.49739682 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.48722998 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.33855019 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.28155019 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.27418373 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25543557 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24929248 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.23305067 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17826844 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 2.14842615 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.11545543 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03188171 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.01941693 |
| 36 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.96991547 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.93082570 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.88180362 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84248041 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81672120 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79273722 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.77919922 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76729428 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.74950769 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.70031659 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67576850 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65484702 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65271551 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63630650 |
| 50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62645202 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61764890 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55687277 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53603121 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47850478 |
| 55 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.47621616 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45074728 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43634704 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42051336 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41911192 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39052667 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38724911 |
| 62 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.37177046 |
| 63 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.36107295 |
| 64 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35878310 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35486966 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33458483 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30969177 |
| 68 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30667551 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28054722 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27225189 |
| 71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26280293 |
| 72 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.23781607 |
| 73 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22555905 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20685226 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16573187 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16484871 |
| 77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15782130 |
| 78 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14117769 |
| 79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13655190 |
| 80 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.12430788 |
| 81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12409361 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09748500 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06805772 |
| 84 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05111805 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04438300 |
| 86 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.03460551 |
| 87 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02839448 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01335460 |
| 89 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01039560 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 1.00595088 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00453691 |
| 92 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99635855 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99153416 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99144099 |
| 95 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98566711 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97998905 |
| 97 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95807408 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94695611 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93823510 |
| 100 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93423773 |
| 101 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92996665 |
| 102 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.92920764 |
| 103 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.92538778 |
| 104 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92070699 |
| 105 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91415866 |
| 106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91211823 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90840606 |
| 108 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90577018 |
| 109 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.90483916 |
| 110 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89891195 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88808646 |
| 112 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88580537 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88295963 |
| 114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87932927 |
| 115 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.87886390 |
| 116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87584756 |
| 117 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87156831 |
| 118 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.86322255 |
| 119 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84698259 |
| 120 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84094989 |
| 121 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82976779 |
| 122 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82140042 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82115555 |
| 124 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82061914 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82025144 |
| 126 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81149077 |
| 127 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76598299 |
| 128 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75066383 |
| 129 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.74202215 |
| 130 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73492068 |
| 131 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72870308 |
| 132 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.71887237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 6.53609249 |
| 2 | MP0001835_abnormal_antigen_presentation | 5.00731289 |
| 3 | MP0001800_abnormal_humoral_immune | 4.75235799 |
| 4 | MP0001790_abnormal_immune_system | 3.87483415 |
| 5 | MP0005387_immune_system_phenotype | 3.87483415 |
| 6 | MP0002452_abnormal_antigen_presenting | 3.54333474 |
| 7 | MP0003724_increased_susceptibility_to | 3.35102452 |
| 8 | MP0005671_abnormal_response_to | 3.31927555 |
| 9 | MP0003300_gastrointestinal_ulcer | 3.30153597 |
| 10 | MP0002723_abnormal_immune_serum | 3.03048330 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.86430106 |
| 12 | MP0001819_abnormal_immune_cell | 2.80182168 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.73954359 |
| 14 | MP0005275_abnormal_skin_tensile | 2.66451578 |
| 15 | MP0002398_abnormal_bone_marrow | 2.66283660 |
| 16 | MP0000716_abnormal_immune_system | 2.60509698 |
| 17 | MP0000685_abnormal_immune_system | 2.58954652 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 2.49545585 |
| 19 | MP0000689_abnormal_spleen_morphology | 2.41771841 |
| 20 | MP0001879_abnormal_lymphatic_vessel | 2.19631363 |
| 21 | MP0005025_abnormal_response_to | 2.16694141 |
| 22 | MP0005503_abnormal_tendon_morphology | 2.14507405 |
| 23 | MP0003436_decreased_susceptibility_to | 2.14147395 |
| 24 | MP0002429_abnormal_blood_cell | 2.09719422 |
| 25 | MP0004782_abnormal_surfactant_physiolog | 2.00385261 |
| 26 | MP0003045_fibrosis | 1.96841831 |
| 27 | MP0002722_abnormal_immune_system | 1.95014313 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.92277394 |
| 29 | MP0002419_abnormal_innate_immunity | 1.87585228 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.86577403 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.86489331 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.83376351 |
| 33 | MP0003866_abnormal_defecation | 1.77502260 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.77414527 |
| 35 | MP0002796_impaired_skin_barrier | 1.76398555 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.73409526 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.69291662 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.69189465 |
| 39 | MP0001873_stomach_inflammation | 1.59916452 |
| 40 | MP0004947_skin_inflammation | 1.58362736 |
| 41 | MP0006054_spinal_hemorrhage | 1.42967985 |
| 42 | MP0002405_respiratory_system_inflammati | 1.41700470 |
| 43 | MP0005166_decreased_susceptibility_to | 1.39168931 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.38555709 |
| 45 | MP0000858_altered_metastatic_potential | 1.38239423 |
| 46 | MP0009785_altered_susceptibility_to | 1.37733982 |
| 47 | MP0002933_joint_inflammation | 1.35659511 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.31864874 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.30287750 |
| 50 | MP0004510_myositis | 1.26811886 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.26008487 |
| 52 | MP0002006_tumorigenesis | 1.21534129 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.20211092 |
| 54 | MP0001851_eye_inflammation | 1.18045229 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.16969771 |
| 56 | MP0010307_abnormal_tumor_latency | 1.16098836 |
| 57 | MP0004858_abnormal_nervous_system | 1.15440736 |
| 58 | MP0001270_distended_abdomen | 1.12394127 |
| 59 | MP0005310_abnormal_salivary_gland | 1.11510496 |
| 60 | MP0004147_increased_porphyrin_level | 1.10910365 |
| 61 | MP0005390_skeleton_phenotype | 1.10433010 |
| 62 | MP0001663_abnormal_digestive_system | 1.10198319 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.08922670 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.08911382 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.05324650 |
| 66 | MP0008260_abnormal_autophagy | 1.03111165 |
| 67 | MP0001853_heart_inflammation | 1.02255494 |
| 68 | MP0003868_abnormal_feces_composition | 1.02028073 |
| 69 | MP0002168_other_aberrant_phenotype | 1.00576527 |
| 70 | MP0002139_abnormal_hepatobiliary_system | 0.98530949 |
| 71 | MP0001216_abnormal_epidermal_layer | 0.98185399 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.98090235 |
| 73 | MP0009840_abnormal_foam_cell | 0.98003812 |
| 74 | MP0008004_abnormal_stomach_pH | 0.97129999 |
| 75 | MP0002060_abnormal_skin_morphology | 0.96637727 |
| 76 | MP0001533_abnormal_skeleton_physiology | 0.96307504 |
| 77 | MP0008874_decreased_physiological_sensi | 0.96056808 |
| 78 | MP0008469_abnormal_protein_level | 0.95920152 |
| 79 | MP0000681_abnormal_thyroid_gland | 0.95898438 |
| 80 | MP0005164_abnormal_response_to | 0.94254884 |
| 81 | MP0003448_altered_tumor_morphology | 0.93593774 |
| 82 | MP0003279_aneurysm | 0.93138741 |
| 83 | MP0000733_abnormal_muscle_development | 0.92035937 |
| 84 | MP0003252_abnormal_bile_duct | 0.91876964 |
| 85 | MP0009931_abnormal_skin_appearance | 0.91664423 |
| 86 | MP0003075_altered_response_to | 0.90742218 |
| 87 | MP0003828_pulmonary_edema | 0.89797794 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.89729786 |
| 89 | MP0008872_abnormal_physiological_respon | 0.88528473 |
| 90 | MP0000490_abnormal_crypts_of | 0.87851142 |
| 91 | MP0006082_CNS_inflammation | 0.86840034 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.86211309 |
| 93 | MP0008569_lethality_at_weaning | 0.84841588 |
| 94 | MP0003191_abnormal_cellular_cholesterol | 0.84206754 |
| 95 | MP0002998_abnormal_bone_remodeling | 0.84170578 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.82590598 |
| 97 | MP0000343_altered_response_to | 0.80869543 |
| 98 | MP0005501_abnormal_skin_physiology | 0.80229852 |
| 99 | MP0005076_abnormal_cell_differentiation | 0.79844009 |
| 100 | MP0000920_abnormal_myelination | 0.79498592 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.75542640 |
| 102 | MP0005360_urolithiasis | 0.75537474 |
| 103 | MP0002896_abnormal_bone_mineralization | 0.75369947 |
| 104 | MP0009763_increased_sensitivity_to | 0.75026132 |
| 105 | MP0000604_amyloidosis | 0.75015333 |
| 106 | MP0003091_abnormal_cell_migration | 0.74268300 |
| 107 | MP0000371_diluted_coat_color | 0.73937355 |
| 108 | MP0004084_abnormal_cardiac_muscle | 0.73625495 |
| 109 | MP0009046_muscle_twitch | 0.73505752 |
| 110 | MP0000377_abnormal_hair_follicle | 0.73438663 |
| 111 | MP0003787_abnormal_imprinting | 0.73098081 |
| 112 | MP0009764_decreased_sensitivity_to | 0.72312112 |
| 113 | MP0000579_abnormal_nail_morphology | 0.72041386 |
| 114 | MP0003566_abnormal_cell_adhesion | 0.71175606 |
| 115 | MP0005023_abnormal_wound_healing | 0.70039654 |
| 116 | MP0000609_abnormal_liver_physiology | 0.69502633 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68764015 |
| 118 | MP0008873_increased_physiological_sensi | 0.67832376 |
| 119 | MP0005381_digestive/alimentary_phenotyp | 0.67374457 |
| 120 | MP0000477_abnormal_intestine_morphology | 0.63885861 |
| 121 | MP0002083_premature_death | 0.63065048 |
| 122 | MP0001944_abnormal_pancreas_morphology | 0.63054529 |
| 123 | MP0001919_abnormal_reproductive_system | 0.62268398 |
| 124 | MP0010352_gastrointestinal_tract_polyps | 0.60885034 |
| 125 | MP0008875_abnormal_xenobiotic_pharmacok | 0.58794257 |
| 126 | MP0005451_abnormal_body_composition | 0.55913407 |
| 127 | MP0002254_reproductive_system_inflammat | 0.55123289 |
| 128 | MP0005220_abnormal_exocrine_pancreas | 0.54736526 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.54232451 |
| 130 | MP0002133_abnormal_respiratory_system | 0.52916398 |
| 131 | MP0005388_respiratory_system_phenotype | 0.52916398 |
| 132 | MP0000003_abnormal_adipose_tissue | 0.52718050 |
| 133 | MP0003795_abnormal_bone_structure | 0.50411751 |
| 134 | MP0009643_abnormal_urine_homeostasis | 0.47281396 |
| 135 | MP0005085_abnormal_gallbladder_physiolo | 0.45386431 |
| 136 | MP0002169_no_abnormal_phenotype | 0.44525794 |
| 137 | MP0002873_normal_phenotype | 0.44368139 |
| 138 | MP0000249_abnormal_blood_vessel | 0.44058898 |
| 139 | MP0001191_abnormal_skin_condition | 0.43751040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Colitis (HP:0002583) | 8.75010273 |
| 2 | B lymphocytopenia (HP:0010976) | 8.06694353 |
| 3 | Abnormality of B cell number (HP:0010975) | 8.06694353 |
| 4 | Recurrent sinusitis (HP:0011108) | 7.03571069 |
| 5 | Inflammation of the large intestine (HP:0002037) | 6.59225318 |
| 6 | Cellulitis (HP:0100658) | 6.55962442 |
| 7 | Gastrointestinal inflammation (HP:0004386) | 6.32912906 |
| 8 | Recurrent bronchitis (HP:0002837) | 6.20129729 |
| 9 | Recurrent viral infections (HP:0004429) | 6.18924301 |
| 10 | Prostate neoplasm (HP:0100787) | 5.95286086 |
| 11 | Papilloma (HP:0012740) | 5.74115178 |
| 12 | Verrucae (HP:0200043) | 5.74115178 |
| 13 | Gastrointestinal stroma tumor (HP:0100723) | 5.42418042 |
| 14 | IgM deficiency (HP:0002850) | 5.21699363 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 5.06033220 |
| 16 | Meningitis (HP:0001287) | 5.02019056 |
| 17 | Abnormality of macrophages (HP:0004311) | 4.89722708 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 4.78358065 |
| 19 | Recurrent pneumonia (HP:0006532) | 4.74425417 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.50385749 |
| 21 | Chronic otitis media (HP:0000389) | 4.35080883 |
| 22 | Recurrent lower respiratory tract infections (HP:0002783) | 4.32103211 |
| 23 | Osteomyelitis (HP:0002754) | 3.87130009 |
| 24 | Abnormality of the prostate (HP:0008775) | 3.86926498 |
| 25 | Chronic sinusitis (HP:0011109) | 3.83872913 |
| 26 | Emphysema (HP:0002097) | 3.64345108 |
| 27 | Recurrent otitis media (HP:0000403) | 3.61399724 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 3.58289438 |
| 29 | Malnutrition (HP:0004395) | 3.58027368 |
| 30 | Bronchitis (HP:0012387) | 3.44135278 |
| 31 | Alopecia of scalp (HP:0002293) | 3.43083382 |
| 32 | Sepsis (HP:0100806) | 3.28826353 |
| 33 | Recurrent fungal infections (HP:0002841) | 3.28751074 |
| 34 | IgA deficiency (HP:0002720) | 3.15837662 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.14377938 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 3.14377938 |
| 37 | Urticaria (HP:0001025) | 3.10730993 |
| 38 | Thyroiditis (HP:0100646) | 3.09712355 |
| 39 | Glomerulonephritis (HP:0000099) | 3.09297634 |
| 40 | Thick nail (HP:0001805) | 3.06315118 |
| 41 | Lymphopenia (HP:0001888) | 3.02436027 |
| 42 | Abnormality of complement system (HP:0005339) | 3.01271310 |
| 43 | Vasculitis (HP:0002633) | 3.00957100 |
| 44 | Skin rash (HP:0000988) | 2.90522853 |
| 45 | Restrictive lung disease (HP:0002091) | 2.90068984 |
| 46 | Viral hepatitis (HP:0006562) | 2.89607689 |
| 47 | Abnormality of nail color (HP:0100643) | 2.87250303 |
| 48 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.86927348 |
| 49 | Leukocytosis (HP:0001974) | 2.80408186 |
| 50 | Abnormality of T cells (HP:0002843) | 2.79604388 |
| 51 | Nephritis (HP:0000123) | 2.79562727 |
| 52 | Hypergammaglobulinemia (HP:0010702) | 2.79503927 |
| 53 | Complement deficiency (HP:0004431) | 2.74489014 |
| 54 | IgG deficiency (HP:0004315) | 2.74179770 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.72391417 |
| 56 | Autoimmune hemolytic anemia (HP:0001890) | 2.72114093 |
| 57 | Recurrent skin infections (HP:0001581) | 2.64185939 |
| 58 | Gingivitis (HP:0000230) | 2.63063201 |
| 59 | Premature loss of primary teeth (HP:0006323) | 2.55440836 |
| 60 | Small epiphyses (HP:0010585) | 2.52606274 |
| 61 | Abnormal hair laboratory examination (HP:0003328) | 2.45927472 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.45825790 |
| 63 | Recurrent bacterial skin infections (HP:0005406) | 2.40901930 |
| 64 | Metaphyseal cupping (HP:0003021) | 2.39743153 |
| 65 | Nasal polyposis (HP:0100582) | 2.39428171 |
| 66 | Recurrent abscess formation (HP:0002722) | 2.38481758 |
| 67 | Gastrointestinal infarctions (HP:0005244) | 2.38164386 |
| 68 | Polycythemia (HP:0001901) | 2.35939869 |
| 69 | Hyperactive renin-angiotensin system (HP:0000841) | 2.35819915 |
| 70 | Right ventricular cardiomyopathy (HP:0011663) | 2.29753974 |
| 71 | Increased IgE level (HP:0003212) | 2.27305035 |
| 72 | Hypochromic microcytic anemia (HP:0004840) | 2.27288933 |
| 73 | Periodontitis (HP:0000704) | 2.27133385 |
| 74 | Erythema (HP:0010783) | 2.25064445 |
| 75 | Palmoplantar hyperkeratosis (HP:0000972) | 2.22567496 |
| 76 | Mitral stenosis (HP:0001718) | 2.21474088 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 2.21437028 |
| 78 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.21437028 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.21437028 |
| 80 | Neutropenia (HP:0001875) | 2.17261725 |
| 81 | Hypermelanotic macule (HP:0001034) | 2.16419591 |
| 82 | Chronic diarrhea (HP:0002028) | 2.15916753 |
| 83 | Skin ulcer (HP:0200042) | 2.15490151 |
| 84 | Ankyloglossia (HP:0010296) | 2.14657887 |
| 85 | Bronchiectasis (HP:0002110) | 2.14147264 |
| 86 | Pulmonary infiltrates (HP:0002113) | 2.13516147 |
| 87 | Encephalitis (HP:0002383) | 2.11562660 |
| 88 | Mediastinal lymphadenopathy (HP:0100721) | 2.10751516 |
| 89 | Abnormality of male internal genitalia (HP:0000022) | 2.10144340 |
| 90 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.08885857 |
| 91 | Neoplasm of the lung (HP:0100526) | 2.06464139 |
| 92 | Pili torti (HP:0003777) | 2.05653745 |
| 93 | Gingival bleeding (HP:0000225) | 2.05529699 |
| 94 | Palmar hyperkeratosis (HP:0010765) | 2.05505808 |
| 95 | Neoplasm of head and neck (HP:0012288) | 2.04250059 |
| 96 | Esophageal neoplasm (HP:0100751) | 2.04250059 |
| 97 | Generalized hypopigmentation of hair (HP:0011358) | 2.00271781 |
| 98 | Agammaglobulinemia (HP:0004432) | 10.4823581 |
| 99 | Abnormality of the nasal mucosa (HP:0000433) | 1.99887452 |
| 100 | Hypochromic anemia (HP:0001931) | 1.99174355 |
| 101 | Vertebral compression fractures (HP:0002953) | 1.97734158 |
| 102 | Hyperparathyroidism (HP:0000843) | 1.94525707 |
| 103 | Plantar hyperkeratosis (HP:0007556) | 1.94343380 |
| 104 | Ileus (HP:0002595) | 1.93603742 |
| 105 | Eczematoid dermatitis (HP:0000976) | 1.93403838 |
| 106 | Leukopenia (HP:0001882) | 1.91557522 |
| 107 | Microcytic anemia (HP:0001935) | 1.90980724 |
| 108 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.90119500 |
| 109 | Villous atrophy (HP:0011473) | 1.90119500 |
| 110 | Follicular hyperkeratosis (HP:0007502) | 1.89780762 |
| 111 | Dysostosis multiplex (HP:0000943) | 1.89098809 |
| 112 | Hemoptysis (HP:0002105) | 1.87692093 |
| 113 | Nonimmune hydrops fetalis (HP:0001790) | 1.86587526 |
| 114 | T lymphocytopenia (HP:0005403) | 1.85630135 |
| 115 | Abnormality of T cell number (HP:0011839) | 1.85268548 |
| 116 | Abnormality of the fingertips (HP:0001211) | 1.84073883 |
| 117 | Purpura (HP:0000979) | 1.83657258 |
| 118 | Granulocytopenia (HP:0001913) | 1.83365781 |
| 119 | Acrocyanosis (HP:0001063) | 1.83201309 |
| 120 | Fragile skin (HP:0001030) | 1.82404333 |
| 121 | Hepatitis (HP:0012115) | 1.79237318 |
| 122 | Vacuolated lymphocytes (HP:0001922) | 1.78958661 |
| 123 | Severe combined immunodeficiency (HP:0004430) | 1.76688121 |
| 124 | Combined immunodeficiency (HP:0005387) | 1.76099828 |
| 125 | Lymphoma (HP:0002665) | 1.71853293 |
| 126 | Loss of speech (HP:0002371) | 1.68055363 |
| 127 | Arthralgia (HP:0002829) | 1.67216915 |
| 128 | Basal cell carcinoma (HP:0002671) | 1.66867492 |
| 129 | Thyroid-stimulating hormone excess (HP:0002925) | 1.65914053 |
| 130 | Thrombocytosis (HP:0001894) | 1.65577488 |
| 131 | Dehydration (HP:0001944) | 1.63244596 |
| 132 | Flattened epiphyses (HP:0003071) | 1.63055818 |
| 133 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.61973340 |
| 134 | Obstructive lung disease (HP:0006536) | 1.61943029 |
| 135 | Chronic obstructive pulmonary disease (HP:0006510) | 1.61943029 |
| 136 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.61549550 |
| 137 | Ocular albinism (HP:0001107) | 1.58303696 |
| 138 | Xerostomia (HP:0000217) | 1.54670755 |
| 139 | Pustule (HP:0200039) | 1.53364407 |
| 140 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.50111942 |
| 141 | Myositis (HP:0100614) | 1.48248861 |
| 142 | Hypertensive crisis (HP:0100735) | 1.46443877 |
| 143 | Spondylolisthesis (HP:0003302) | 1.45258440 |
| 144 | Teleangiectasia of the skin (HP:0100585) | 1.44270990 |
| 145 | Prominent nose (HP:0000448) | 1.43680004 |
| 146 | Abnormality of the lumbar spine (HP:0100712) | 1.42103747 |
| 147 | Thoracic kyphosis (HP:0002942) | 1.41582930 |
| 148 | Hypoplasia of the thymus (HP:0000778) | 1.40123762 |
| 149 | Autoimmune thrombocytopenia (HP:0001973) | 1.39683383 |
| 150 | Chest pain (HP:0100749) | 1.38096949 |
| 151 | Abnormal foot bone ossification (HP:0010675) | 1.34348758 |
| 152 | Abnormality of the common coagulation pathway (HP:0010990) | 1.34008304 |
| 153 | Macroorchidism (HP:0000053) | 1.33795919 |
| 154 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.32210430 |
| 155 | Mucopolysacchariduria (HP:0008155) | 1.32210430 |
| 156 | Alacrima (HP:0000522) | 1.32143681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.52765426 |
| 2 | MAP4K1 | 5.36272206 |
| 3 | PRPF4B | 3.61681877 |
| 4 | EEF2K | 3.20901001 |
| 5 | TAOK3 | 2.95927154 |
| 6 | MAP3K10 | 2.95537030 |
| 7 | RIPK4 | 2.74635850 |
| 8 | GRK6 | 2.73583779 |
| 9 | EIF2AK3 | 2.39766904 |
| 10 | TYK2 | 2.39026981 |
| 11 | SYK | 2.20561752 |
| 12 | IRAK3 | 2.12239070 |
| 13 | CSF1R | 2.09461460 |
| 14 | RIPK1 | 2.09157672 |
| 15 | BLK | 1.98179885 |
| 16 | SIK2 | 1.97845438 |
| 17 | TNIK | 1.75407838 |
| 18 | KIT | 1.74086272 |
| 19 | MAP2K3 | 1.67617573 |
| 20 | FES | 1.64991611 |
| 21 | MST1R | 1.64620010 |
| 22 | NME2 | 1.59166269 |
| 23 | MAP3K14 | 1.58199618 |
| 24 | JAK1 | 1.55287910 |
| 25 | EPHA3 | 1.55256102 |
| 26 | BTK | 1.52656174 |
| 27 | TBK1 | 1.52202063 |
| 28 | MAP3K6 | 1.51114902 |
| 29 | SIK3 | 1.43375300 |
| 30 | PRKCH | 1.43159026 |
| 31 | IKBKB | 1.39958928 |
| 32 | STK10 | 1.26551999 |
| 33 | LYN | 1.23591024 |
| 34 | MAP3K13 | 1.23388428 |
| 35 | IKBKE | 1.19914803 |
| 36 | EPHA2 | 1.17911030 |
| 37 | ITK | 1.17217145 |
| 38 | HCK | 1.14645762 |
| 39 | IRAK4 | 1.12130224 |
| 40 | HIPK2 | 1.10184142 |
| 41 | CDK3 | 1.09768847 |
| 42 | JAK3 | 1.07452825 |
| 43 | STK24 | 1.05993524 |
| 44 | LRRK2 | 1.05092752 |
| 45 | CDK12 | 1.04981670 |
| 46 | MET | 1.01162566 |
| 47 | TGFBR1 | 1.01112299 |
| 48 | MAP3K1 | 0.98054958 |
| 49 | YES1 | 0.97275612 |
| 50 | MAPK7 | 0.96328092 |
| 51 | ZAP70 | 0.95981636 |
| 52 | RPS6KA4 | 0.94207030 |
| 53 | PAK4 | 0.91573955 |
| 54 | PRKD2 | 0.91221793 |
| 55 | MAP3K4 | 0.89536829 |
| 56 | PRKCQ | 0.87724632 |
| 57 | NLK | 0.86270862 |
| 58 | CDK6 | 0.85789453 |
| 59 | FGFR4 | 0.82468835 |
| 60 | TGFBR2 | 0.81373699 |
| 61 | TXK | 0.79695180 |
| 62 | MAPK12 | 0.78128596 |
| 63 | PIK3CA | 0.77735164 |
| 64 | CSK | 0.77651407 |
| 65 | LCK | 0.77370563 |
| 66 | DYRK1B | 0.76795863 |
| 67 | TAOK1 | 0.76545641 |
| 68 | PIK3CG | 0.76239203 |
| 69 | NUAK1 | 0.75600135 |
| 70 | TEC | 0.74029291 |
| 71 | PIM1 | 0.73787425 |
| 72 | SMG1 | 0.73617180 |
| 73 | TRIB3 | 0.72519163 |
| 74 | NEK2 | 0.70999747 |
| 75 | MAP3K3 | 0.68560638 |
| 76 | ALK | 0.64971920 |
| 77 | NEK9 | 0.64225882 |
| 78 | FGFR3 | 0.63748255 |
| 79 | DDR2 | 0.63037925 |
| 80 | PDGFRA | 0.58847958 |
| 81 | BMX | 0.57282985 |
| 82 | SIK1 | 0.55879656 |
| 83 | EIF2AK1 | 0.55714595 |
| 84 | MAP3K7 | 0.55326971 |
| 85 | CLK1 | 0.54889295 |
| 86 | FER | 0.53276180 |
| 87 | PDPK1 | 0.52664690 |
| 88 | PDK1 | 0.51400011 |
| 89 | MAPK11 | 0.50314558 |
| 90 | MELK | 0.49543393 |
| 91 | FYN | 0.49162078 |
| 92 | RPS6KB2 | 0.47942845 |
| 93 | STK4 | 0.45416636 |
| 94 | CHUK | 0.45018957 |
| 95 | BMPR2 | 0.44567744 |
| 96 | MAPKAPK3 | 0.43292421 |
| 97 | MAP2K4 | 0.42500673 |
| 98 | PRKD1 | 0.42213105 |
| 99 | PKN2 | 0.41551168 |
| 100 | MAP2K6 | 0.40496981 |
| 101 | EPHB1 | 0.40388091 |
| 102 | JAK2 | 0.38941373 |
| 103 | MAP3K9 | 0.37027531 |
| 104 | TESK2 | 0.36832882 |
| 105 | BRD4 | 0.35882733 |
| 106 | EGFR | 0.35100138 |
| 107 | MST4 | 0.34288027 |
| 108 | MARK3 | 0.34042059 |
| 109 | DMPK | 0.33371673 |
| 110 | TAOK2 | 0.33360497 |
| 111 | INSR | 0.32247837 |
| 112 | ARAF | 0.32240174 |
| 113 | PKN1 | 0.31644851 |
| 114 | MAPKAPK2 | 0.31619087 |
| 115 | MAPK3 | 0.31469668 |
| 116 | CDK4 | 0.31381718 |
| 117 | ACVR1B | 0.31256298 |
| 118 | KSR2 | 0.30909538 |
| 119 | RAF1 | 0.28260102 |
| 120 | CSNK1A1L | 0.28139520 |
| 121 | FLT3 | 0.27537631 |
| 122 | MAPK4 | 0.27033573 |
| 123 | MAP2K1 | 0.26962935 |
| 124 | FGR | 0.25772207 |
| 125 | CDK9 | 0.25531247 |
| 126 | MARK2 | 0.25467773 |
| 127 | MAP3K11 | 0.25370608 |
| 128 | PRKCD | 0.25024989 |
| 129 | ABL1 | 0.23123541 |
| 130 | PRKCI | 0.21315254 |
| 131 | RET | 0.20753358 |
| 132 | CSNK1G3 | 0.20596958 |
| 133 | IGF1R | 0.20178029 |
| 134 | CDC42BPA | 0.19269908 |
| 135 | IRAK1 | 0.17774533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 7.21273765 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.09765850 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.69190633 |
| 4 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.88135639 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.58362379 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.36093108 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.27965925 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.16850312 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11457739 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87864708 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81751929 |
| 12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.76136583 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.76021447 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.74866926 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.67725328 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67506386 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63327466 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62713782 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.52248462 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.42773087 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41541591 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.28682980 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.22149174 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18310216 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18141903 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17486645 |
| 27 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.16101440 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12056250 |
| 29 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02334672 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01471434 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99806184 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98320278 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96909031 |
| 34 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.95817859 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 0.95674946 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95365231 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 0.93065900 |
| 38 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92804555 |
| 39 | Malaria_Homo sapiens_hsa05144 | 0.92329980 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91914856 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91045211 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89574023 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88247641 |
| 44 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87231532 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86671455 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86575225 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 0.86440102 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86023321 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84715115 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83324270 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82914281 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.81859420 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.81770488 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80847847 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80640040 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.80401127 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80269293 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79415324 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.78371334 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78130876 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77337217 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.76543491 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.75243616 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.74626571 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74043155 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72777458 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72251782 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71792093 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71699769 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.71043355 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70464366 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70069317 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69467054 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68906290 |
| 75 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.68886789 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.68596957 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.66623076 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.66110581 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65941282 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65745494 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65521750 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65342655 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64964033 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64000501 |
| 85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63985556 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61642703 |
| 87 | Allograft rejection_Homo sapiens_hsa05330 | 0.59872363 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59236681 |
| 89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56251092 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55654748 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.55294499 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54700302 |
| 93 | Lysine degradation_Homo sapiens_hsa00310 | 0.54581194 |
| 94 | Base excision repair_Homo sapiens_hsa03410 | 0.54194080 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53114243 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50233527 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50021121 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.48258778 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.47735506 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47681648 |
| 101 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47260941 |
| 102 | Bladder cancer_Homo sapiens_hsa05219 | 0.46995299 |
| 103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46586209 |
| 104 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46403910 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46004691 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44938176 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44851624 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43038103 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43030272 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40983284 |
| 111 | Cocaine addiction_Homo sapiens_hsa05030 | 0.40529594 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39863493 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37039579 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36657385 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35116145 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31112303 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.29286126 |
| 118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.28929936 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.28452926 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27781490 |
| 121 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.26091871 |
| 122 | Renin secretion_Homo sapiens_hsa04924 | 0.25691424 |
| 123 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.25684083 |
| 124 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.25621804 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | 0.25548954 |
| 126 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22679583 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21945606 |
| 128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20537151 |
| 129 | Insulin secretion_Homo sapiens_hsa04911 | 0.19922153 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19467117 |
| 131 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.19407350 |
| 132 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.18777879 |
| 133 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.18682715 |
| 134 | Salmonella infection_Homo sapiens_hsa05132 | 0.18140481 |
| 135 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.17536786 |

